Published in Bone Marrow Transplant on September 19, 2016
Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: a randomised controlled trial. ANRS 048 study group. Lancet (1999) 1.35
Toxoplasmosis after hematopoietic stem cell transplantation. Clin Infect Dis (2000) 1.34
A randomized trial of high- versus low-dose subcutaneous interleukin-2 outpatient therapy for early human immunodeficiency virus type 1 infection. J Infect Dis (1999) 1.26
Ultra low-dose IL-2 for GVHD prophylaxis after allogeneic hematopoietic stem cell transplantation mediates expansion of regulatory T cells without diminishing antiviral and antileukemic activity. Clin Cancer Res (2014) 1.17
Toxoplasmic encephalitis IRIS in HIV-infected patients: a case series and review of the literature. J Neurol Neurosurg Psychiatry (2010) 1.09
A prospective study of diagnosis of Toxoplasma gondii infection after bone marrow transplantation. APMIS (2008) 1.05
Disseminated toxoplasmosis after bone marrow transplantation: report of 9 cases. Transpl Infect Dis (2001) 1.01
Disseminated toxoplasmosis after bone marrow transplantation: high-resolution CT appearance. J Thorac Imaging (2004) 0.89
Imaging characteristics of toxoplasmosis encephalitis after bone marrow transplantation: report of two cases and review of the literature. Neuroradiology (2005) 0.88
Toxoplasmosis encephalitis following severe graft-vs.-host disease after allogeneic hematopoietic stem cell transplantation: 17 yr experience in Fukuoka BMT group. Eur J Haematol (2007) 0.86
Opportunistic infections and immune reconstitution inflammatory syndrome in HIV-1-infected adults in the combined antiretroviral therapy era: a comprehensive review. Expert Rev Anti Infect Ther (2015) 0.86
A two-step approach to allogeneic haploidentical hematopoietic stem cell transplantation. Semin Oncol (2012) 0.83
Activated microglia contribute to neuronal apoptosis in Toxoplasmic encephalitis. Parasit Vectors (2014) 0.83
Paradoxical immune reconstitution inflammatory syndrome due to toxoplasmic encephalitis: two cases and review of initiation of antiretroviral timing in toxoplasmic encephalitis IRIS. F1000Res (2013) 0.82